» Articles » PMID: 17330784

High Rates of Forward Transmission Events After Acute/early HIV-1 Infection

Abstract

Background: A population-based phylogenetic approach was used to characterize human immunodeficiency virus (HIV)-transmission dynamics in Quebec.

Methods: HIV-1 pol sequences included primary HIV infections (PHIs; <6 months after seroconversion) from the Quebec PHI cohort (1998-2005; n=215) and the provincial genotyping program (2001-2005; n=481). Phylogenetic analysis determined sequence interrelationships among unique PHIs (n=593) and infections from untreated (n=135) and treated (n=660) chronically infected (CI) potential transmitter populations (2001-2005). Clinical features, risk factors, and drug resistance for clustered and nonclustered transmission events were ascertained.

Results: Viruses from 49.4% (293/593) of PHIs cosegregated into 75 transmission chains with 2-17 transmissions/cluster. Half of the clusters included 2.7+/-0.8 (mean+/-SD) transmissions, whereas the remainder had 8.8+/-3.5 transmissions. Maximum periods for onward transmission in clusters were 15.2+/-9.5 months. Coclustering of untreated and treated CIs with PHIs were infrequent (6.2% and 4.8%, respectively). The ages, viremia, and risk factors were similar for clustered and nonclustered transmission events. Low prevalence of drug resistance in PHI supported amplified transmissions at early stages.

Conclusions: Early infection accounts for approximately half of onward transmissions in this urban North American study. Therapy at early stages of disease may prevent onward HIV transmission.

Citing Articles

Dynamics of clustering rates in the Rhode Island HIV-1 epidemic.

Novitsky V, Steingrimsson J, Guang A, Dunn C, Howison M, Gillani F AIDS. 2024; 39(2):105-114.

PMID: 39527774 PMC: 11717628. DOI: 10.1097/QAD.0000000000004062.


Clinical-epidemiological profile and factors associated with viral non-suppression in patients living with HIV/AIDS assisted at the Integrated Treatment Center at the Maputo Military Hospital (CITRA/MMH), 2019 to 2020.

Chicanequisso E, Sema Baltazar C, Sacarlal J BMC Infect Dis. 2024; 24(1):713.

PMID: 39033267 PMC: 11265015. DOI: 10.1186/s12879-024-09616-2.


Characterising HIV-1 transmission in Victoria, Australia: a molecular epidemiological study.

Taiaroa G, Chibo D, Herman S, Taouk M, Gooey M, DCosta J Lancet Reg Health West Pac. 2024; 47:101103.

PMID: 38953059 PMC: 11215101. DOI: 10.1016/j.lanwpc.2024.101103.


Identification of a circulating long non-coding RNA signature panel in plasma as a novel biomarker for the detection of acute/early-stage HIV-1 infection.

Biswas S, Nagarajan N, Hewlett I, Devadas K Biomark Res. 2024; 12(1):61.

PMID: 38867244 PMC: 11167902. DOI: 10.1186/s40364-024-00597-7.


The Phenomenon of Antiretroviral Drug Resistance in the Context of Human Immunodeficiency Virus Treatment: Dynamic and Ever Evolving Subject Matter.

Apetroaei M, Velescu B, Nedea M, Dinu-Pirvu C, Draganescu D, Faca A Biomedicines. 2024; 12(4).

PMID: 38672269 PMC: 11048092. DOI: 10.3390/biomedicines12040915.